Ads
related to: severe asthma treatments- Pay As Little As $0
Get Information About A Savings
Program & Learn If You Are Eligible
- What Is E-Asthma?
Visit The Official Patient Site To
Learn About Your Asthma Condition.
- Sign Up For Email Updates
Receive Personalized Resources For
Your Asthma Journey, Sign Up.
- Find An Asthma Specialist
Take Control Of Your Asthma
Condition & Find A Doctor Near You.
- Patient Support Tools
Access Different Asthma Resources
That Are Available To You.
- Self-Injection Option
View Resources & Frequent Questions
About This Self-Admin Injection.
- Pay As Little As $0
Search results
GSK says its experimental drug reduced asthma attacks with only two doses a year
Quartz· 7 days agoPeople suffering from a severe form of asthma could soon see their symptoms improve with a new...
GSK’s Potential Blockbuster Asthma Drug Shows Promise in Latest Trial
The Wall Street Journal· 7 days agoHEALTH NEWS GSK’s experimental drug for asthma met its goals in the latest trial, moving a treatment...
Research finds few moderate or severe asthma patients prescribed recommended inhaler regimen
Medical Xpress· 7 days agoIn the United States, ICS-formoterol inhalers include Symbicort (budesonide-formoterol) and Dulera...
GSK Studies on Depemokimab for Severe Asthma Meet Primary Goals
Zacks· 6 days agoGSK's depemokimab has the potential to become the first ultra-long-acting biologic for severe asthma with a six-month dosing schedule
Biotech Stock Roundup: BIIB's Acquisition, PTCT, LRMR Gain on Updates & More News
Zacks via Yahoo Finance· 5 days agoThis decision was based on top-line data from the phase I/II ALSpire study, wherein treatment with...
AstraZeneca’s fasenra asthma drug shows promise for COPD treatment
BioPharma-Reporter· 7 days agoThis approval extends Fasenra's availability to over 80 countries, including the US, EU, and Japan....
Northeast Ohio Black Health Coalition promotes air quality and asthma awareness
WFMJ Youngstown· 4 days agoThose who suffer from asthma attacks know an attack can be severe, or even fatal. But not everyone...
The Zacks Analyst Blog Highlights Biogen, Ionis Pharmaceuticals, GSK, PTC Therapeutics and Larimar...
Zacks via Yahoo Finance· 4 days agoThis decision was based on top-line data from the phase I/II ALSpire study, wherein treatment with...
Dr. Cynthia Maro: Entering worst months for pet allergies
Gannett via AOL· 2 days agoWhen pets suffer from multiple or severe allergies, treatment with medications and nutritional...
Tezepelumab Shows Potential for COPD, Negative Trial Notwithstanding
MedPage Today· 6 days agoAsthma drug may benefit patients with blood eosinophil counts indicative of type 2 inflammation
Ad
related to: severe asthma treatments